Annual mammography with screening ultrasound may benefit women at increased risk of breast cancer

April 3, 2012, JAMA and Archives Journals

The addition of a screening ultrasound or magnetic resonance imaging (MRI) to annual mammography in women with an increased risk of breast cancer and dense breast tissue resulted in a higher rate of detection of incident breast cancers, according to a study in the April 4 issue of JAMA.

"Annual ultrasound screening may detect small, node-negative breast cancers that are not seen on . may reveal additional breast cancers missed by both mammography and ultrasound screening," according to background information in the article.

Wendie A. Berg, M.D., Ph.D., formerly of the American College of Radiology Imaging Network, Philadelphia, and colleagues conducted a study to determine the supplemental cancer detection yield of ultrasound and MRI in women at elevated risk for breast cancer. The study included 2,809 women (with increased and dense breasts) at 21 sites who consented to 3 annual independent screens with mammography and ultrasound in randomized order. at enrollment was 55 years. Nearly 54 percent of women had a of breast cancer. After 3 rounds of both screenings, 612 of 703 women who chose to undergo an MRI had complete data.

A total of 2,662 women underwent 7,473 mammogram and ultrasound screenings, 110 of whom had 111 breast cancer events. Fifty-nine cancers (53 percent) were detected by mammography, including 33 (30 percent) that were detected by mammography only; 32 (29 percent) by ultrasound only; and 9 (8 percent) by MRI only after both mammography and ultrasound screens failed to detect cancer. Eleven cancers (10 percent) were not detected by any imaging screen. A total of 16 of 612 women (2.6 percent) in the MRI substudy were diagnosed with .

Among 4,814 incidence screens in the second and third years combined, 75 women were diagnosed with cancer. The researchers found that supplemental ultrasound increased cancer detection with each annual screen beyond that of mammography, adding detection of 5.3 cancers per 1,000 women in the first year; 3.7 women per 1,000 per year in each of the second and third years; and averaging 4.3 per 1,000 for each of the 3 rounds of annual screening. The addition of MRI screening further increased cancer detection with a supplemental yield of 14.7 per 1,000 women. The number of screens needed to detect 1 cancer was 127 for mammography; 234 for supplemental ultrasound, and 68 for supplemental MRI after negative mammography plus ultrasound screening results.

"Despite its higher sensitivity, the addition of screening MRI rather than ultrasound to mammography in broader populations of women at intermediate risk with dense breasts may not be appropriate, particularly when the current high false-positive rates, cost, and reduced tolerability of MRI are considered," the authors conclude.

Explore further: High-risk, underserved women benefited from MRI screening for breast cancer

More information: JAMA. 2012;307[13]:1394-1404.

Related Stories

High-risk, underserved women benefited from MRI screening for breast cancer

September 20, 2011
Using breast magnetic resonance imaging (MRI) screenings among targeted, high-risk, underserved women significantly decreased diagnostic cost and increased patient compliance rates with follow-up compared to using general ...

Recommended for you

'Kiss of death' cancer: How computational geeks may have uncovered a therapy for a deadly disease

June 19, 2018
It's called the 'kiss of death'. Triple negative breast cancer has no targeted drug therapy and, as such, the only hope for these patients is chemotherapy. Triple negative breast cancer is aggressive and deadly. Patients ...

Ovarian cancer cells switched off by 'unusual' mechanism

June 19, 2018
Scientists at the Ovarian Cancer Action Research Centre at Imperial College London have discovered a mechanism that deactivates ovarian cancer cells.

Breast cancer could be prevented by targeting epigenetic proteins, study suggests

June 19, 2018
Researchers at the Princess Margaret Cancer Centre in Toronto have discovered that epigenetic proteins promote the proliferation of mammary gland stem cells in response to the sex hormone progesterone. The study, which will ...

Team discovers gene mutations linked to pancreatic cancer

June 19, 2018
Six genes contain mutations that may be passed down in families, substantially increasing a person's risk for pancreatic cancer. That's according to Mayo Clinic research published in the June 19 edition of the JAMA. However, ...

Targeting the engine room of the cancer cell

June 18, 2018
Researchers at Columbia University Irving Medical Center (CUIMC) have developed a highly innovative computational framework that can support personalized cancer treatment by matching individual tumors with the drugs or drug ...

Study suggests well-known growth suppressor actually fuels lethal brain cancers

June 18, 2018
Scientists report finding a potentially promising treatment target for aggressive and deadly high-grade brain cancers like glioblastoma. But they also say the current lack of a drug that hits the molecular target keeps it ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.